Medicines Regulatory Systems and Scope for Regulatory Harmonization in Southeast Asia
Ensuring access to essential medicines is a key objective of all health systems, and is an integral component of the progress towards universal health coverage (UHC). Despite global and national efforts to improve access and affordability of medicines, millions of people – particularly in low- an...
| Main Authors: | , , |
|---|---|
| Format: | Report |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2017
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/727671496171008743/Medicines-regulatory-systems-and-scope-for-regulatory-harmonization-in-Southeast-Asia http://hdl.handle.net/10986/26801 |
| Summary: | Ensuring access to essential medicines is a key objective of all health systems, and is
an integral component of the progress towards universal health coverage (UHC).
Despite global and national efforts to improve access and affordability of medicines,
millions of people – particularly in low- and middle-income countries – still remain without
access to quality-assured and affordable medicines. This study aims to contribute to existing knowledge on regulatory systems and
harmonization efforts in Southeast Asia. Focusing on five member states of the
Association of Southeast Asian Nations (ASEAN) – Indonesia, Malaysia, the Philippines,
Thailand, an Vietnam – this study gives an overview of pharmaceutical markets and key
pharmaceutical policies in the region, provides a cross-country comparison of medicines
regulatory systems, and details harmonization efforts, opportunities, and challenges. |
|---|